On the 28th, an Indonesian Food and Drug Authority (BPOM) pharmaceutical delegation visited Daewoong Pharmaceutical’s Magok research center in Korea as part of its trip to attend the Global Bio‑Conference 2026.
The delegation examined Daewoong’s new‑drug and biopharmaceutical R&D system and infrastructure. Both parties discussed possible cooperation on product development, regulatory approval, and business expansion within Indonesia, as well as future clinical development and related regulatory matters.
규제 업데이트2026년 9월 14일•3분 읽기
Indonesian BPOM delegation visits Daewoong Pharma’s Magok R&D center to explore collaboration
An Indonesian BPOM pharmaceutical delegation toured Daewoong Pharmaceutical’s Magok R&D facility, reviewing new‑drug and biopharma projects and discussing joint development and approval pathways in Indonesia.
Pharmacountry 팀이 정리했습니다 · 출처: KPA News
주제:
평점
(0)
(0)
(0)
(0)
(0)
평가 남기기